602 related articles for article (PubMed ID: 10975993)
1. Increased serum amyloid a levels reflect colitis severity and precede amyloid formation in IL-2 knockout mice.
de Villiers WJ; Varilek GW; de Beer FC; Guo JT; Kindy MS
Cytokine; 2000 Sep; 12(9):1337-47. PubMed ID: 10975993
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of the major circulating precursors of proteins deposited in secondary amyloidosis by a recombinant mouse interleukin-1 receptor antagonist.
Grehan S; Herbert J; Whitehead AS
Eur J Immunol; 1997 Oct; 27(10):2593-9. PubMed ID: 9368615
[TBL] [Abstract][Full Text] [Related]
3. Involvement of CD14 and toll-like receptor 4 in the acute phase response of serum amyloid A proteins and serum amyloid P component in the liver after burn injury.
Cho K; Pham TN; Crivello SD; Jeong J; Green TL; Greenhalgh DG
Shock; 2004 Feb; 21(2):144-50. PubMed ID: 14752288
[TBL] [Abstract][Full Text] [Related]
4. Anti-interleukin 6 receptor antibody inhibits murine AA-amyloidosis.
Mihara M; Shiina M; Nishimoto N; Yoshizaki K; Kishimoto T; Akamatsu K
J Rheumatol; 2004 Jun; 31(6):1132-8. PubMed ID: 15170926
[TBL] [Abstract][Full Text] [Related]
5. Association of apolipoprotein E with murine amyloid A protein amyloid.
Kindy MS; King AR; Perry G; de Beer MC; de Beer FC
Lab Invest; 1995 Oct; 73(4):469-75. PubMed ID: 7474917
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of the amyloid SAA 3 gene in liver and peritoneal macrophages of mice undergoing dissimilar inflammatory episodes.
Rokita H; Shirahama T; Cohen AS; Meek RL; Benditt EP; Sipe JD
J Immunol; 1987 Dec; 139(11):3849-53. PubMed ID: 3680951
[TBL] [Abstract][Full Text] [Related]
7. Induction and regulation by monokines of hepatic synthesis of the mouse serum amyloid P-component (SAP).
Le PT; Mortensen RF
J Immunol; 1986 Apr; 136(7):2526-33. PubMed ID: 3512716
[TBL] [Abstract][Full Text] [Related]
8. FK506 inhibits murine AA amyloidosis: possible involvement of T cells in amyloidogenesis.
Ueda M; Ando Y; Nakamura M; Yamashita T; Himeno S; Kim J; Sun X; Saito S; Tateishi T; Bergström J; Uchino M
J Rheumatol; 2006 Nov; 33(11):2260-70. PubMed ID: 16981291
[TBL] [Abstract][Full Text] [Related]
9. Antisense oligonucleotide suppression of serum amyloid A reduces amyloid deposition in mice with AA amyloidosis.
Kluve-Beckerman B; Hardwick J; Du L; Benson MD; Monia BP; Watt A; Crooke RM; Mullick A
Amyloid; 2011 Sep; 18(3):136-46. PubMed ID: 21830877
[TBL] [Abstract][Full Text] [Related]
10. The role of fibronectin in the development of experimental amyloidosis. Evidence of immunohistochemical codistribution and binding property with serum amyloid protein A.
Kawahara E; Shiroo M; Nakanishi I; Migita S
Am J Pathol; 1989 Jun; 134(6):1305-14. PubMed ID: 2757120
[TBL] [Abstract][Full Text] [Related]
11. Acute phase induction of mouse serum amyloid P component. Correlation with other parameters of inflammation.
Zahedi K; Whitehead AS
J Immunol; 1989 Nov; 143(9):2880-6. PubMed ID: 2809211
[TBL] [Abstract][Full Text] [Related]
12. Anaemia of chronic disease in AA amyloidosis is associated with allele 2 of the interleukin-1beta-511 promoter gene and raised levels of interleukin-1beta and interleukin-18.
Maury CP; Liljeström M; Laiho K; Tiitinen S; Kaarela K; Hurme M
J Intern Med; 2004 Aug; 256(2):145-52. PubMed ID: 15257727
[TBL] [Abstract][Full Text] [Related]
13. Fenofibrate inhibits reactive amyloidosis in mice.
Murai T; Yamada T; Miida T; Arai K; Endo N; Hanyu T
Arthritis Rheum; 2002 Jun; 46(6):1683-8. PubMed ID: 12115201
[TBL] [Abstract][Full Text] [Related]
14. Ubiquitin: its potential significance in murine AA amyloidogenesis.
Chronopoulos S; Lembo P; Alizadeh-Khiavi K; Ali-Khan Z
J Pathol; 1992 Jun; 167(2):249-59. PubMed ID: 1321903
[TBL] [Abstract][Full Text] [Related]
15. Expression of a biologically active recombinant mouse IL-1 receptor antagonist and its use in vivo to modulate aspects of the acute phase response.
Grehan S; Uhlar CM; Sim RB; Herbert J; Whitehead AS
J Immunol; 1997 Jul; 159(1):369-78. PubMed ID: 9200475
[TBL] [Abstract][Full Text] [Related]
16. Use of genetically altered mice to study the role of serum amyloid P component in amyloid deposition.
Maeda S
Amyloid; 2003 Aug; 10 Suppl 1():17-20. PubMed ID: 14640037
[TBL] [Abstract][Full Text] [Related]
17. Brefeldin A inhibits experimentally induced AA amyloidosis.
Stenstad T; Husby G
J Rheumatol; 1996 Jan; 23(1):93-100. PubMed ID: 8838515
[TBL] [Abstract][Full Text] [Related]
18. Deposition, Clearance, and Reinduction of Amyloid A Amyloid in Interleukin 1 Receptor Antagonist Knockout Mice.
Watanabe K; Uchida K; Chambers JK; Ushio N; Nakayama H
Vet Pathol; 2017 Jan; 54(1):99-110. PubMed ID: 27565681
[TBL] [Abstract][Full Text] [Related]
19. In vivo fragmentation of heparan sulfate by heparanase overexpression renders mice resistant to amyloid protein A amyloidosis.
Li JP; Galvis ML; Gong F; Zhang X; Zcharia E; Metzger S; Vlodavsky I; Kisilevsky R; Lindahl U
Proc Natl Acad Sci U S A; 2005 May; 102(18):6473-7. PubMed ID: 15843464
[TBL] [Abstract][Full Text] [Related]
20. Is the serum amyloid A protein in acute phase plasma high density lipoprotein the precursor of AA amyloid fibrils?
Baltz ML; Rowe IF; Caspi D; Turnell WG; Pepys MB
Clin Exp Immunol; 1986 Dec; 66(3):701-8. PubMed ID: 3105937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
